1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. Europe Breast Cancer Screening Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. Europe Breast Cancer Screening Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1
- 5.1.2 Increasing awareness about early detection
- 5.1.3 Advancements in imaging technologies
- 5.1.4 Government initiatives and funding for cancer screening programs
- 5.1.5 Growing prevalence of breast cancer
- 5.1.6 Rising adoption of minimally invasive diagnostic techniques
- 5.1.7 Improved reimbursement policies for screening procedures
- 5.1.8 Expanding healthcare infrastructure in emerging markets
- 5.1.9 Rising demand for personalized and targeted therapies
- 5.1.10 High healthcare expenditure in developed regions
- 5.1.11 Growing preference for non-invasive screening methods
- 5.1.12 Technological innovations in artificial intelligence for diagnostic accuracy
- 5.1.13 Increase in high-risk population due to genetic factors
- 5.1.14 Enhanced focus on preventive healthcare initiatives
5.2 Market Opportunities
- 5.2.1
- 5.2.2 Expansion of screening programs in developing regions
- 5.2.3 Integration of AI and machine learning in diagnostic tools
- 5.2.4 Development of more accurate and less invasive screening methods
- 5.2.5 Increasing partnerships between public and private sectors for awareness campaigns
- 5.2.6 Growth of telemedicine and remote screening solutions
- 5.2.7 Rising adoption of wearable health devices for early detection
- 5.2.8 Advancements in genetic testing and risk assessment tools
- 5.2.9 Introduction of liquid biopsy for early cancer detection
- 5.2.10 Increase in personalized breast cancer screening protocols
- 5.2.11 Expanding role of mobile health apps in screening and follow-up
- 5.2.12 Growth in home-based testing kits
- 5.2.13 Strategic collaborations for improving accessibility and affordability
5.3 Future Trends
- 5.3.1
- 5.3.2 Integration of AI-driven diagnostic platforms with real-time imaging
- 5.3.3 Increased use of liquid biopsy and molecular screening techniques
- 5.3.4 Personalized screening based on genetic profiling
- 5.3.5 Rise in adoption of at-home and DIY breast cancer screening tests
- 5.3.6 Utilization of 3D mammography and tomosynthesis for improved accuracy
- 5.3.7 Development of multi-cancer early detection tests
- 5.3.8 Growth in digital health platforms for breast cancer monitoring
- 5.3.9 Expansion of AI-based tools for risk stratification and prognosis
- 5.3.10 Increased focus on screening asymptomatic individuals with advanced technologies
- 5.3.11 Introduction of portable and affordable screening devices for remote areas
- 5.3.12 Integration of telehealth for follow-up consultations post-screening
- 5.3.13 Enhanced screening for high-risk populations using advanced genomics
5.4 Impact of Drivers and Restraints
6. Europe Breast Cancer Screening Market Regional Analysis
6.1 Europe Breast Cancer Screening Market Overview
6.2 Europe Breast Cancer Screening Market Revenue 2017-2027 (US$ Million)
6.3 Europe Breast Cancer Screening Market Forecast Analysis
7. Europe Breast Cancer Screening Market Analysis – by Test Type
7.1 Blood Marker Test
- 7.1.1 Overview
- 7.1.2 Blood Marker Test: Europe Breast Cancer Screening Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Imaging Test
- 7.2.1 Overview
- 7.2.2 Imaging Test: Europe Breast Cancer Screening Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Genetic Test
- 7.3.1 Overview
- 7.3.2 Genetic Test: Europe Breast Cancer Screening Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Immunohistochemistry Test
- 7.4.1 Overview
- 7.4.2 Immunohistochemistry Test: Europe Breast Cancer Screening Market – Revenue and Forecast to 2031 (US$ Million)
8. Europe Breast Cancer Screening Market Analysis – by End User
8.1 Hospitals
- 8.1.1 Overview
- 8.1.2 Hospitals: Europe Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)
8.2 Diagnostic Centers
- 8.2.1 Overview
- 8.2.2 Diagnostic Centers: Europe Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)
8.3 Cancer Institutes
- 8.3.1 Overview
- 8.3.2 Cancer Institutes: Europe Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Research Laboratories
- 8.4.1 Overview
- 8.4.2 Research Laboratories: Europe Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)
9. Europe Breast Cancer Screening Market – Europe Analysis
9.1 Europe
- 9.1.1 Europe Breast Cancer Screening Market Breakdown, by Key
Country, 2020 and 2027 (%)
- 9.1.1.1 Europe Breast Cancer Screening Market – Revenue and
Forecast Analysis – by Country
- 9.1.1.1 UK:
Europe Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)
- 9.1.1.1.1 UK: Europe Breast Cancer Screening Market Breakdown, by Test Type
- 9.1.1.1.2 UK: Europe Breast Cancer Screening Market Breakdown, by End User
- 9.1.1.2 Germany:
Europe Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)
- 9.1.1.2.1 Germany: Europe Breast Cancer Screening Market Breakdown, by Test Type
- 9.1.1.2.2 Germany: Europe Breast Cancer Screening Market Breakdown, by End User
- 9.1.1.3 France:
Europe Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)
- 9.1.1.3.1 France: Europe Breast Cancer Screening Market Breakdown, by Test Type
- 9.1.1.3.2 France: Europe Breast Cancer Screening Market Breakdown, by End User
- 9.1.1.4 Russia:
Europe Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)
- 9.1.1.4.1 Russia: Europe Breast Cancer Screening Market Breakdown, by Test Type
- 9.1.1.4.2 Russia: Europe Breast Cancer Screening Market Breakdown, by End User
- 9.1.1.5 Italy:
Europe Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)
- 9.1.1.5.1 Italy: Europe Breast Cancer Screening Market Breakdown, by Test Type
- 9.1.1.5.2 Italy: Europe Breast Cancer Screening Market Breakdown, by End User
- 9.1.1.6 Rest of Europe:
Europe Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)
- 9.1.1.6.1 Rest of Europe: Europe Breast Cancer Screening Market Breakdown, by Test Type
- 9.1.1.6.2 Rest of Europe: Europe Breast Cancer Screening Market Breakdown, by End User
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. Europe Breast Cancer Screening Market Industry Landscape
11.1 Overview
11.2 Mergers and Acquisitions
11.3 Agreements, Collaborations, and Joint Ventures
11.4 New Product Launches
11.5 Expansions and Other Strategic Developments
12. Company Profiles
12.1 Koninklijke Philips N.V.
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Hologic, Inc.
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Becton, Dickinson and Company
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Myriad Genetics, Inc.
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Siemens Healthcare AG
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Exact Sciences Corporation
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 OncoCyte Corporation
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 POC Medical Systems
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 DanaherCorporation
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 General Electric Company
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
13. Appendix
13.1 About Business Market Insights
Get Free Sample For Europe Breast Cancer Screening Market
